NCT05335252
Dronabinol After Arthroscopic Surgery
Active, Not Recruiting
PHASE3Ages 18+InterventionalTreatmentNorthwestern UniversityInvestigator-initiated
~30 participants
Updated 2026-05-27 on ClinicalTrials.gov
What's tested:DronabinolPlacebo
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Opioid consumption
Measured over up to 7 days post-surgery
Conditions
NCT05335252
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Northwestern University Feinberg School of Medicine
Chicago, Illinoisno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Vehniah K Tjong, MD · PRINCIPAL_INVESTIGATOR · Northwestern Feinberg School of Medicine
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age 18 years or older
Patient who will undergo arthroscopic surgery of the knee including, but not limited to,
Meniscectomy
Synovectomy
Chondroplasty
Loose body removal
Exclusion
Patients under age 18 years
Patients who cannot provide consent
Patients who are pregnant, breast feeding, or are trying to become pregnant during the study period
Patients with an allergy to any of the study drugs
Patient who are lactose-intolerant
Revision surgery
Open surgery
Comorbidities preventing surgery
Patients with a history of mania, depression, or schizophrenia
Patients taking any of the following drugs or supplements
Anticholinergic agents
Benzodiazepines
Central nervous system depressants
Droperidol
Hydroxyzine
Levomepromazine or methotrimeprazine
Monoamine oxidase inhibitors
Ritonavir
Selective serotonin reuptake inhibitors
Sympathomimetics
St. John's Wort
Current diagnosed alcohol or drug abuse
Patients who cannot or will not abide by the medication restrictions listed below
Participants must agree to abstain from using recreational or medical marijuana products or cannabidiol (CBD) in any form during the treatment period
Participants should not drink alcohol or take other drugs while taking the study drug or hydrocodone/acetaminophen
What this trial measures
- Opioid consumptionup to 7 days post-surgery
Count of number of hydrocodone/acetaminophen tablet consumed